Market Tracker

02/28 7:33am ET

Bio Rad Laboratories Inc (NYSE:BIO)

196.83
Delayed Data
As of Feb 27
 +4.91 / +2.56%
Today’s Change
130.17
Today|||52-Week Range
197.63
+7.98%
Year-to-Date
New Strong Sell Stocks for February 22nd
Feb 22 / Zacks.com - Paid Partner Content
New Strong Sell Stocks for February 17th
Feb 17 / Zacks.com - Paid Partner Content
MedTech Stocks' Earnings Due on Feb 23: TFX, SAUHF, BIO, PDCO
Feb 22 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close191.92
Today’s open192.16
Day’s range191.61 - 197.63
Volume241,667
Average volume (3 months)174,973
Market cap$4.8B
Dividend yield--
Data as of 02/27/2017

Growth & Valuation

Earnings growth (last year)-75.32%
Earnings growth (this year)+195.09%
Earnings growth (next 5 years)-4.24%
Revenue growth (last year)+2.41%
P/E ratio59.1
Price/Sales2.61
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BRKRBruker Corp-0.18-0.72%
PKIPerkinElmer Inc-0.05-0.09%
QGENQiagen NV+0.60+2.13%
AXDXAccelerate Diagnosti...+0.35+1.32%
Data as of 02/27/2017

Financials

Next reporting dateMay 9, 2017
EPS forecast (this quarter)$0.58
Annual revenue (last year)$2.1B
Annual profit (last year)$28.1M
Net profit margin1.36%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Norman D. Schwartz
Chief Operating Officer &
Executive Vice President
John Goetz
Corporate headquarters
Hercules, California

Forecasts